High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3H (H-2K(k)) murine model

Virus Research

Volumn 50, Issue 2, 1997, Pages 159-173

  Stokes, A ^a,b   Cameron, R S ^a   Marshall, R N ^a   Killington, R A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

Author keywords

Recombinant EHV 1 glycoproteins D and H

Indexed keywords

BETA GALACTOSIDASE; HYBRID PROTEIN; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; VIRUS GLYCOPROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EQUINE HERPES VIRUS; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; VIRUS INFECTION;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; DISEASE MODELS, ANIMAL; GENETIC VECTORS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; LUNG; MICE; MICE, INBRED C3H; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; TURBINATES; VIRAL ENVELOPE PROTEINS; WEIGHT LOSS;

ANIMALIA; EQUIDAE; EQUINE HERPESVIRUS 1; HERPES; HERPESVIRIDAE; HERPESVIRUS 1; INSECTA; MURINAE; UNIDENTIFIED BACULOVIRUS;

EID: 0030870633     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(97)00067-1     Document Type: Article

References (47)

1. d) mice. Res. Vet. Sci. 59, 205-213.
2. Allen, G.P., Yeargen, M.R., Turtinen, L.W., Bryans, J.T., McCollum, W.H., 1983. Molecular epizootiologic studies of equine herpesvirus-1 infections by restriction endonuclease fingerprinting of viral DNA. Am. J. Vet. Res. 44, 263-271.
3. Allen, G.P., Bryans, J.T., 1986. Molecular epizootiology, pathogenesis and prophylaxis of equine herpesvirus-1 infections. Prog. Vet. Microbiol. Immunol. 2, 78-144.
4. Awan, A.P., Chong, Y.-C., Field, H.J., 1990. The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. J. Gen. Virol. 71, 1131-1140.
5. Burke, R.L., 1993. Recent developments in herpes simplex virus vaccines. Semin. Virol. 5, 261-271.
6. Burrows, R., Goodridge, D., Denyer, M.S., 1984. Trials of an inactivated equid herpesvirus 1 vaccine: Challenge with a subtype-1 virus. Vet. Rec. 114, 369-374.
7. Coignoul, F.L., Bertram, T.A., Cheville, N.F., 1984. Pathogenicity of equine herpesvirus 1 subtype-2 for foals and adult pony mares. Vet. Micro. 9, 533-542.
8. Crabb, B.S., Macpherson, C.M., Reubel, G.H., Browning, G.F., Studdert, M.J., Drummer, H.E., 1995. A type-specific serological test to distinguish antibodies to equine herpesvirus 4 and 1. Arch. Virol. 140, 245-258.
9. Crossen, R.E., Gruenwald, S., 1995. The 6 × His expression and purification system. In: Baculovirus glutathione s-transferase and 6 × His Kits: High Level Expression and Purification Systems, 2nd ed., Pharmingen, 10975 Torreyana Road, San Diego, CA 92121, USA, pp. 9-14.
10. Desai, P.J., Schaffer, P.A., Minson, A.C., 1988. Excretion of non-infectious virus particles lacking glycoprotein H by a temperature sensitive mutant of herpes simplex virus type 1: evidence that gH is essential for virion infectivity. J. Gen. Virol. 69, 1147-1156.
11. Doll, E.R., 1961. Immunization against viral rhinopneumonitis of horses with live virus propagated in hamsters. J. Am. Vet. Med. Assoc. 139, 1324-1336.
12. Drew, M.D., Estrada-Correa, A., Underdown, B.J., McDermott, M.R., 1992. Vaccination by cholera toxin conjugated to a herpes simplex virus type 2 glycoprotein D peptide. J. Gen. Virol. 73, 2357-2366.
13. Eisenberg, R.J., Ponce de Lyon, M., Pereira, L., Long, D., Cohen, G.H., 1982. Purification of glycoprotein gD of herpes simplex virus types 1 and 2 by use of monoclonal antibody. J. Virol. 41, 1099-1104.
14. Farrell, H.E., McLean, C.S., Harley, C., Efstathiou, S., Inglis, S., Minson, A.C., 1994. Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted. J. Virol. 68, 927-932.
15. Flowers, C., O'Callaghan, D.J., 1992. Equine herpesvirus 1 glycoprotein D: Mapping of the transcript and a neutralization epitope. J. Virol. 66, 6451-6460.
16. Flowers, C.C., Flowers, S.P., Jennings, S.R., O'Callaghan, D.J., 1995a. Synthesis and processing of equine herpesvirus 1 glycoprotein D. Virology 208, 9-18.
17. Flowers, C.C., Flowers, S.P., Sheng, Y., Tarbet, E.B., Jennings, S.R., O'Callaghan, D.J., 1995b. Expression of membrane-bound and secreted forms of equine herpesvirus 1 glycoprotein D by recombinant baculovirus. Virus Res. 35, 17-34.
18. Ghiasi, H., Kaiwar, R., Nesburn, A.B., Wechsler, S.L., 1992. Baculovirus expressed glycoprotein H of herpes simplex virus type-1 (HSV-1) induces neutralizing antibody and delayed type hypersensitivity responses, but does not protect immunized mice against lethal HSV-1 challenge. J. Gen. Virol. 73, 719-722.
19. Giles, R.C., Donahue, J.M., Hong, C.B., Tuttle, P.A., Petrites-Murphy, M.B., Poonacha, K.B., Roberts, A.W., Tramontin, R.R., Smith, B., Swerczek, T.W., 1993. Causes of abortion, stillbirth, and perinatal death in horses: 3527 cases (1986-1991). J. Am. Vet. Med. Assoc. 203, 1170-1175.
20. Compels, U.A., Minson, A.C., 1989. Antigenic properties and cellular localization of herpes simplex virus glycoprotein H synthesized in a mammalian cell expression system. J. Virol. 63, 4744-4755.
21. Hazama, M., Mayumi-Aono, A., Miyazaki, T., Hinuma, S., Fujisawa, Y., 1993. Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2. Immunology 78, 643-649.
22. Ligas, M.W., Johnson, D.C., 1988. A herpes simplex virus mutant in which gD sequences are replaced with by betagalactosidase sequences binds to but is unable to penetrate into cells. J. Virol. 62, 1486-1494.
23. Long, D., Cohen, G.H., Muggeridge, M.I., Eisenberg, R.J., 1990. Cysteine mutants of herpes simplex virus type 1 glycoprotein D exhibit temperature-sensitive properties in structure and function. J. Virol. 64, 5542-5552.
24. Love, D.N., Bell, C.W., Pye, D., Edwards, S., Hayden, M., Lawrence, G.L., Boyle, D., Pye, T., Whalley, J.M., 1993. Expression of equine herpesvirus 1 glycoprotein D by using a baculovirus recombinant. J. Virol. 67, 6820-6823.
25. Matsumara, T., Sugiura, T., Imagawa, H., Fukunaga, Y., Kamada, M., 1992. Epizootiological aspects of type 1 and type 4 equine herpesvirus infections among horse populations. J. Vet. Med. Sci. 54, 207-211.
26. McGowan, E.M., Hayden, M.B., Edwards, S.J., Pye, D., Love, D.N., Whalley, J.M., 1994. Expression and characterisation of equine herpesvirus 1 glycoprotein H using a recombinant baculovirus. Arch. Virol. 137, 389-395.
27. Meredith, D.M., Stocks, J.-M., Whittaker, G.R., Halliburton, I.W., Snowden, B.W., Killington, R.A., 1989. Identification of the gB homologues of equine herpesvirus types 1 and 4 as disulphide-linked heterodimers and their characterization using monoclonal antibodies. J. Gen. Virol. 70, 1161-1172.
28. Mumford, J.A., Bates, J., 1984. Trials of an inactivated equid herpesvirus 1 vaccine: Challenge with a subtype-2 virus. Vet. Rec. 114, 375-381.
29. Nakao, M., Hazama, M., Mayumi-Aono, A., Hinuma, S., Fujisawa, Y., 1994. Immunotherapy of acute and recurrent herpes simplex virus 2 infection with an adjuvant-free form of recombinant glycoprotein D-interleukin-2 fusion protein. J. Inf. Dis. 169, 787-791.
30. Osterrieder, N., Wagner, R., Pfeffer, M., Kaaden, O.R., 1994. Expression of equine herpesvirus type 1 glycoprotein gp 14 in Escherichia coli and in insect cells: a comparative study on protein processing and humoral immune responses. J. Gen. Virol. 75, 2041-2046.
31. Osterrieder, N., Wagner, R., Brandmuller, C., Schmidt, P., Wolf, H., Kaaden, O.-R., 1995. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology 208, 500-510.
32. Peeters, B., de Wind, N., Broer, R., Gielkens, A., Moorman, B., 1992. Glycoprotein H of pseudorabies virus is essential for entry and cell-cell spread of the virus. J. Virol. 66, 3888-3892.
33. Robertson, G.R., Scott, N.A., Miller, J.M., Sabine, M., Zheng, M., Bell, C.R., Whalley, J.M., 1991. Sequence characteristics of a gene in equine herpesvirus 1 homologous to glycoprotein H of herpes simplex virus. DNA Seq. 1, 241-249.
34. Sabine, M., Robertson, G.R., Whalley, J.M., 1981. Differentiation of subtypes of equine herpesvirus-1 by restriction endonuclease analysis. Aust. Vet. J. 57, 148-149.
35. Sisk, W.P., Bradley, J.D., Leipold, R.J., Stoltzfus, A.M., Ponce de Lyon, M., Hilf, M., Peng, C., Cohen, G.H., Eisenberg, R.J., 1994. High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells. J. Virol. 68, 766-775.
36. Staats, H.F., Oakes, J.E., Lausch, R.N., 1991. Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type-1 induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1 + cells. J. Virol. 65, 6008-6014.
37. Stokes, A., Allen, G.P., Pullen, L.A., Murray, P.K., 1989. A hamster model of equine herpesvirus type 1 (EHV-1) infection; passive protection by monoclonal antibodies to EHV-1 glycoproteins 13, 14 and 17/18. J. Gen. Virol. 70, 1173-1183.
38. Stokes, A., Alber, D.G., Greensill, J., Amellal, B., Carvalho, R., Taylor, L.A., Doel, T.R., Killington, R.A., Halliburton, I.W., Meredith, D.M., 1996a. The expression of the proteins of equine herpesvirus 1 which share homology with herpes simplex virus 1 glycoproteins H and L. Virus Res. 40, 91-107.
39. k) mice against virus challenge. Virus Res. 44, 97-109.
40. Studdert, M.J., Simpson, T., Roizman, B., 1981. Differentiation of respiratory and abortigenic isolates of EHV 1 by restriction endonucleases. Science 214, 562-564.
41. Tewari, D., Whalley, J.M., Love, D.N., Field, H.J., 1994. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. J. Gen. Virol. 75, 1735-1741.
42. van Drunen Littel-van den Hurk, S., Parker, M.D., Massie, B., van den Hurk, J.V., Harland, R., Babiuk, L.A., Zamb, T.J., 1993. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine 11, 25-35.
43. Weijer, W.J., Drifhout, J.W., Geerligs, H.J., Bloemhoff, W., Feijlbrief, M., Bos, C.A., Hoogerhout, P., Kerling, K.E., Popken-Boer, T., Slopsema, K., 1988. Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro. J. Virol. 62, 501-510.
44. Wellington, J.E., Gooley, A.A., Love, D.N., Whalley, J.M., 1996a. N-terminal sequence analysis of equine herpesvirus 1 glycoproteins D and B and evidence for internal cleavage of the gene 71 product. J. Virol. 77, 75-82.
45. Wellington, J.E., Lawrence, G.L., Love, D.N., Whalley, J.M., 1996b. Expression and characterization of equine herpesvirus 1 glycoprotein D in mammalian cell lines. Arch. Virol. 141, 1785-1793.
46. Whittaker, G.R., Taylor, L.A., Elton, D.M., Giles, L.E., Bonass, W.A., Halliburton, I.W., Killington, R.A., Meredith, D.M., 1992. Glycoprotein 60 of equine herpesvirus type 1 is a homologue of herpes simplex virus glycoprotein D and plays a major role in penetration of cells. J. Gen. Virol. 73, 801-809.
47. Wilcox, W.C., Long, D., Sodora, D.L., Eisenberg, R.J., 1988. The contribution of cysteine residues to antigenicity and extent of processing of herpes simplex virus type 1 glycoprotein D. J. Virol. 62, 1941-1947.